CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Biomed Lublin Wytwornia Surowic I Szczepionek SA Company Snapshot
Biomed Lublin Wytwornia Surowic I Szczepionek SA operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Biomed Lublin Wytwornia Surowic I Szczepionek SA with three other pharmaceutical manufacturers in Europe: Transgene of FRANCE (2019 sales of 13.30 million Euros [US$15.04 million] of which 50% was Bio-Production & Cooperations), CO.DON AG of GERMANY (6.86 million Euros [US$7.76 million] of which 100% was Product sales), and Erytech Pharma SA which is based in FRANCE (5.28 million Euros [US$5.98 million] of which 100% was Pharmacy).

Sales Analysis. Biomed Lublin Wytwornia Surowic I Szczepionek SA reported sales of 39.11 million Polish New Zlotys (US$9.91 million) for the year ending December of 2019. This represents an increase of 21.1% versus 2018, when the company's sales were 32.29 million Polish New Zlotys.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Biomed Lublin Wytwornia Surowic I Szczepionek SA
  Stock Performance Chart for Biomed Lublin Wytwornia Surowic I Szczepionek SA
 
  Stock Data: Recent Stock Performance:
  Current Price (7/3/2020): 7.88
(Figures in Polish New Zlotys)
1 Week 1.3%   13 Weeks 102.6%  
4 Weeks 85.4%   52 Weeks 688.0%  
 
Biomed Lublin Wytwornia Surowic I Szczepionek SA Key Data:
  Ticker: BML Country: Poland
  Exchanges: WAR Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2019 Sales 39,107,000
(Year Ending Jan 2020).
Employees: 230
  Currency: Polish New Zlotys Market Cap: 490,612,031
  Fiscal Yr Ends: December Shares Outstanding: 62,260,410
  Share Type: Akcje Closely Held Shares: 28,188,112
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.